Schwab Charles Investment Management Inc. lifted its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 2.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 994,780 shares of the health services provider’s stock after acquiring an additional 27,796 shares during the quarter. Schwab Charles Investment Management Inc. owned 0.74% of Select Medical worth $19,100,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the company. Citadel Advisors LLC boosted its stake in shares of Select Medical by 117.1% during the 3rd quarter. Citadel Advisors LLC now owns 114,370 shares of the health services provider’s stock worth $2,196,000 after acquiring an additional 61,694 shares in the last quarter. Virginia Retirement Systems ET AL purchased a new stake in shares of Select Medical during the 3rd quarter worth approximately $486,000. Legal & General Group Plc boosted its stake in shares of Select Medical by 1.3% during the 3rd quarter. Legal & General Group Plc now owns 301,340 shares of the health services provider’s stock worth $5,786,000 after acquiring an additional 3,880 shares in the last quarter. American International Group Inc. boosted its stake in shares of Select Medical by 5.6% during the 3rd quarter. American International Group Inc. now owns 84,931 shares of the health services provider’s stock worth $1,631,000 after acquiring an additional 4,488 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Select Medical during the 3rd quarter worth approximately $505,000. 77.89% of the stock is currently owned by institutional investors and hedge funds.

Shares of Select Medical Holdings Co. (SEM) opened at $16.55 on Wednesday. Select Medical Holdings Co. has a 52 week low of $12.00 and a 52 week high of $19.77. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 3.36. The stock has a market capitalization of $2,194.72, a P/E ratio of 20.76, a P/E/G ratio of 1.29 and a beta of 1.35.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Select Medical had a net margin of 2.21% and a return on equity of 11.44%. Select Medical’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.06 EPS. equities analysts forecast that Select Medical Holdings Co. will post 0.85 earnings per share for the current year.

A number of equities research analysts recently issued reports on SEM shares. ValuEngine raised Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research lowered Select Medical from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Deutsche Bank reaffirmed a “buy” rating and issued a $22.00 target price on shares of Select Medical in a research note on Monday, November 6th. Robert W. Baird reaffirmed a “buy” rating and issued a $21.00 target price on shares of Select Medical in a research note on Tuesday, October 17th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $19.00 target price on shares of Select Medical in a research note on Friday, October 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $19.50.

In other Select Medical news, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $18.97, for a total value of $350,945.00. Following the completion of the transaction, the insider now directly owns 340,044 shares in the company, valued at approximately $6,450,634.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Martin F. Jackson sold 156,603 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total value of $2,671,647.18. Following the completion of the transaction, the insider now owns 1,790,601 shares of the company’s stock, valued at $30,547,653.06. The disclosure for this sale can be found here. Insiders sold a total of 180,103 shares of company stock valued at $3,112,442 over the last quarter. 19.93% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Select Medical Holdings Co. (SEM) Shares Bought by Schwab Charles Investment Management Inc.” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/select-medical-holdings-co-sem-shares-bought-by-schwab-charles-investment-management-inc/1774225.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.